LANGUAGE
KOREANENGLISH
LOCATION
  • COMPANY
  • R&D
    • R&D Institute
    • GMP Center
    • Clinical Development Status
    • Publications
  • PRODUCTS
    • 1st Generation
      • Overview
      • CARTISTEM®
      • PNEUMOSTEM®
    • 2nd Generation
      • Overview
      • SMUP-IA-01
      • SMUP-IV-01
    • R&D Inquiries
  • BUSINESS
    • CDMO
      • CDMO Service
      • Core Value
      • Manufacturing
      • Global CDMO
      • CDMO Inquiries
    • CELLTREE Cord Blood Bank
    • MOVITA Nutritional Supplements
    • LUCATREE Advanced Regenerative Medicine
  • IR
    • Stock Information
    • Disclosure
    • Financial Information
    • IR Inquiries
  • PR
    • MEDIPOST on Media
    • Corporate Brochure
  • CONTACT US
    • Customer Center
    • R&D Inquiries
    • CDMO Inquiries
    • IR Inquiries

MEDIPOST Selected as Outstanding Taxpayer

2016/03/04
MEDIPOST

On the ‘50th Taxpayer’s Day’, MEDIPOST was selected as an ‘Outstanding Taxpayer’ by Gyeonggi Province.

Companies selected as Outstanding Taxpayers are those that have no unpaid local taxes and have diligently paid their local taxes within the 3-year payment deadline. Outstanding taxpayers are selected through an evaluation conducted by a Local Tax Deliberation Committee.

MEDIPOST was selected as an outstanding taxpayer this year for its diligent tax payments and MEDIPOST President Hwang Dong-jin received a certificate from the Vice-Governor Lee Jae-yul of Gyeonggi Province at the certificate ceremony held on March 3.

MEDIPOST will be exempt from local tax audits for a set period and receive financial incentives.

VIEW LIST

Related News

MEDIPOST, selected as a “Excellent Disclosure Corporation” b…
2018/04/18

Latest News

knee img
MEDIPOST Inc. Treats First U.S. Participant in Phase III Tri…
2026/07/07
cdmo img33
MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Stu…
2026/06/04
news
MEDIPOST’s CARTISTEM® Meets All Primary and Secondary…
2026/05/13
medipost img 2
MEDIPOST, INC. ANNOUNCES $140 MILLION IN FUNDING TO ACCELERA…
2026/01/09
knee img
MEDIPOST Inc. Treats First U.S. Participant in Phase III Tri…
2026/07/07
cdmo img33
MEDIPOST Secures FDA Agreement on Single Pivotal Phase 3 Stu…
2026/06/04
news
MEDIPOST’s CARTISTEM® Meets All Primary and Secondary…
2026/05/13
medipost img 2
MEDIPOST, INC. ANNOUNCES $140 MILLION IN FUNDING TO ACCELERA…
2026/01/09

Contacts

21, Daewangpangyo-ro 644, Bundang-gu, Seongnam-si, Gyeonggi-do, Korea MEDIPOST Co., Ltd.
TEL : 82-2-3465-6677

Latest News

MEDIPOST Inc. Treats First U.S. Particip…2026.07.07
MEDIPOST Secures FDA Agreement on Single…2026.06.04
MEDIPOST’s CARTISTEM® Meets All Pr…2026.05.13
MEDIPOST, INC. ANNOUNCES $140 MILLION IN…2026.01.09
MEDIPOST Announces the Exclusive Commerc…2025.12.19

Family Site

· CELLTREE Cord Blood Bank
· MOVITA Nutritional Supplements

· LOCATION
· PRIVACY POLICY

©Copyright – The Future of Biotechnology, MEDIPOST